YBGJ — Yubo International Biotech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Yubo International Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1.54	-1.2	-1.2	-1.98	-1.19
Depreciation
Non-Cash Items	0.008	—	—	0.212	—
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.492	0.577	0.266	0.249	0.167
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-1.02	-0.601	-0.739	-1.34	-0.843
Capital Expenditures	-0.565	-0.04	0	—	—
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	—	—	0.118	0
Sale of Fixed Assets
Cash from Investing Activities	-0.565	-0.04	0	0.118	0
Financing Cash Flow Items	—	0.669	0.746	1.41	0.85
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities	0.127	0.669	0.746	1.41	0.85
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-1.36	-0.009	-0.012	0.001	0.001